KLRK1
From Wikipedia, the free encyclopedia
Killer cell lectin-like receptor subfamily K, member 1
|
|||||
PDB rendering based on 1hyr. | |||||
Available structures: 1hyr, 1kcg, 1mpu | |||||
Identifiers | |||||
Symbol(s) | KLRK1; CD314; D12S2489E; KLR; NKG2-D; NKG2D | ||||
External IDs | MGI: 1196250 HomoloGene: 7209 | ||||
|
|||||
Orthologs | |||||
Human | Mouse | ||||
Entrez | 22914 | 27007 | |||
Ensembl | n/a | ENSMUSG00000030149 | |||
Uniprot | n/a | Q2TJJ6 | |||
Refseq | NM_007360 (mRNA) NP_031386 (protein) |
XM_001004553 (mRNA) XP_001004553 (protein) |
|||
Location | n/a | Chr 6: 129.58 - 129.59 Mb | |||
Pubmed search | [1] | [2] |
Killer cell lectin-like receptor subfamily K, member 1, also known as KLRK1, is a human gene. KLRK1 has also been designated as CD314 (cluster of differentiation 314).
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. D12S2489E is a member of the NKG2 group which are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells. The first non-coding exon at the 5' end of the D12S2489E transcript is included in the 3' end of the KLRC4 transcript.[1]
[edit] References
[edit] Further reading
- Raulet DH (2003). "Roles of the NKG2D immunoreceptor and its ligands.". Nat. Rev. Immunol. 3 (10): 781–90. doi: . PMID 14523385.
- Lanier LL (2004). "NKG2D.". J. Biol. Regul. Homeost. Agents 17 (4): 338–40. PMID 15065764.
- Coudert JD, Held W (2006). "The role of the NKG2D receptor for tumor immunity.". Semin. Cancer Biol. 16 (5): 333–43. doi: . PMID 16914326.
- Houchins JP, Yabe T, McSherry C, Bach FH (1991). "DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.". J. Exp. Med. 173 (4): 1017–20. PMID 2007850.
- Spertini O, Frei PC (1986). "Biophysical properties and morphology of purified antigen associated with non-A, non-B hepatitis.". Med. Microbiol. Immunol. 175 (4): 229–39. PMID 2426565.
- Plougastel B, Trowsdale J (1998). "Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes.". Eur. J. Immunol. 27 (11): 2835–9. PMID 9394807.
- Plougastel B, Trowsdale J (1998). "Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes.". Genomics 49 (2): 193–9. doi: . PMID 9598306.
- Glienke J, Sobanov Y, Brostjan C, et al. (1998). "The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.". Immunogenetics 48 (3): 163–73. PMID 9683661.
- Li P, Willie ST, Bauer S, et al. (1999). "Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand.". Immunity 10 (5): 577–84. PMID 10367903.
- Bauer S, Groh V, Wu J, et al. (1999). "Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.". Science 285 (5428): 727–9. PMID 10426993.
- Wu J, Song Y, Bakker AB, et al. (1999). "An activating immunoreceptor complex formed by NKG2D and DAP10.". Science 285 (5428): 730–2. PMID 10426994.
- Cosman D, Müllberg J, Sutherland CL, et al. (2001). "ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.". Immunity 14 (2): 123–33. PMID 11239445.
- Diefenbach A, Jamieson AM, Liu SD, et al. (2001). "Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.". Nat. Immunol. 1 (2): 119–26. doi: . PMID 11248803.
- Li P, Morris DL, Willcox BE, et al. (2001). "Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.". Nat. Immunol. 2 (5): 443–51. doi: . PMID 11323699.
- Shum BP, Flodin LR, Muir DG, et al. (2002). "Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.". J. Immunol. 168 (1): 240–52. PMID 11751968.
- Radaev S, Rostro B, Brooks AG, et al. (2002). "Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3.". Immunity 15 (6): 1039–49. PMID 11754823.
- Sutherland CL, Chalupny NJ, Schooley K, et al. (2002). "UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.". J. Immunol. 168 (2): 671–9. PMID 11777960.
- Holmes MA, Li P, Petersdorf EW, Strong RK (2002). "Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D.". J. Immunol. 169 (3): 1395–400. PMID 12133964.
- Groh V, Wu J, Yee C, Spies T (2002). "Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.". Nature 419 (6908): 734–8. doi: . PMID 12384702.
- Gilfillan S, Ho EL, Cella M, et al. (2002). "NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.". Nat. Immunol. 3 (12): 1150–5. doi: . PMID 12426564.
[edit] External links
- MeSH KLRK1+protein,+human
- Volker Huppert. NKG2D - NKcells.info. Retrieved on 2008-03-06.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.